SYL040012
Showing 1 - 4 of 4
Open Angle Glaucoma, Ocular Hypertension Trial in Worldwide (1 drop of 0.375% SYL040012 (bamosiran), 1 drop of 0.750% SYL040012
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- 1 drop of 0.375% SYL040012 (bamosiran)
- +4 more
-
Artesia, California
- +20 more
Dec 11, 2020
Ocular Hypertension, Open Angle Glaucoma Trial in Estonia, Germany, Spain (SYL040012, Placebo)
Completed
- Ocular Hypertension
- Open Angle Glaucoma
- SYL040012
- Placebo
-
Tallin, Estonia
- +10 more
Jun 7, 2013
Glaucoma, Ocular Hypertension Trial in Pamplona, Madrid (SYL040012)
Completed
- Glaucoma
- Ocular Hypertension
- SYL040012
-
Pamplona, Navarra, Spain
- +1 more
Sep 26, 2012
Ocular Hypertension, Glaucoma Trial in Pamplona (SYL040012)
Completed
- Ocular Hypertension
- Glaucoma
- SYL040012
-
Pamplona, Navarra, SpainClinica Universidad de Navarra
Oct 21, 2010